Form 4: MODD Director Vos Granted 7,500 Stock Options

Modular Medical, Inc. Director Ellen O'Connor Vos received a grant of 7,500 stock options, fully vested and exercisable at $0.36 per share.

Summary

• Ellen O'Connor Vos, a Director of Modular Medical, Inc. (MODD), was granted 7,500 options to purchase common stock.
• The options have an exercise price of $0.36 per share.
• The grant date was December 31, 2025, and the options were fully vested and exercisable on this date.
• The options expire on December 31, 2035.
• This grant was made in accordance with the Issuer's Outside Director Compensation Plan.

Sentiment

Score: 5

Explanation: This is a neutral, routine insider transaction filing reporting a director's compensation grant. It does not inherently indicate positive or negative company performance or outlook.

Positives

• The grant aligns the director's interests with those of shareholders, as the value of the options increases with the company's stock price.
• It represents a standard component of compensation for outside directors, indicating established corporate governance practices.

Future Outlook

This Form 4 filing is a report of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan.
• The option was fully vested and exercisable on the grant date.

Industry Context

The grant of stock options to an outside director is a common practice in publicly traded companies, serving to align the director's long-term interests with those of shareholders and to provide competitive compensation for their oversight responsibilities.

Comparison to Industry Standards

• Granting stock options as part of director compensation is a widely accepted practice across various industries, including the medical device sector where Modular Medical, Inc. operates.
• The immediate vesting of options for outside directors is also common, reflecting their ongoing service rather than performance-based milestones typically associated with executive grants.
• While specific grant sizes and exercise prices vary by company size, industry, and individual director's tenure, a grant of 7,500 options for an outside director is within a typical range for small to mid-cap companies.

Corporate Governance

Related Party Transactions

• The grant of stock options to Director Ellen O'Connor Vos constitutes a related party transaction as part of her compensation for service on the board.

Stakeholder Impact

• Shareholders: Potential minor dilution if options are exercised, but also improved alignment of director's interests with shareholder value.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• The reporting person may choose to exercise the options at any time between December 31, 2025, and December 31, 2035.
• Upon exercise, the reporting person would acquire 7,500 shares of Modular Medical, Inc. common stock.

Key Dates

Keywords

Modular Medical, MODD, Ellen O'Connor Vos, stock options, director compensation, Form 4, insider transaction, equity grant, corporate governance